Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Helene Blasco, Debora Lanznaster, Charlotte Veyrat-Durebex, Rudolf Hergesheimer, Patrick Vourch, Francois Maillot, Christian R. Andres, Pierre-François Pradat & Phillipe Corcia. (2020) Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis. Expert Review of Neurotherapeutics 20:9, pages 907-919.
Read now
Read now
Gorka FernÁndez-Eulate, JosÉ Ignacio Ruiz-Sanz, Javier Riancho, Monica ZufirÍa, Gorka GereÑu, Roberto FernÁndez-TorrÓn, Juan JosÉ Poza-Aldea, Jon Ondaro, Juan Bautista Espinal, Gonzalo GonzÁlez-ChinchÓn, Miren Zulaica, Maria BegoÑa Ruiz-Larrea, Adolfo LÓpez De Munain & Francisco Javier Gil-Bea. (2020) A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 252-262.
Read now
Read now
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2019) Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 53-60.
Read now
Read now
Cristina Moglia, Andrea Calvo, Antonio Canosa, Davide Bertuzzo, Paolo Cugnasco, Luca Solero, Maurizio Grassano, Enrica Bersano, Stefania Cammarosano, Umberto Manera, Fabrizio Pisano, Letizia Mazzini, Laura A. Dalla Vecchia, Gabriele Mora & Adriano Chiò. (2017) Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 590-597.
Read now
Read now
Articles from other publishers (40)
Teresa Pardo-Moreno, Himan Mohamed-Mohamed, Sami Suleiman-Martos, Juan José Ramos-Rodriguez, Antonio Rivas-Dominguez, Lucía Melguizo-Rodríguez, José L. Gómez-Urquiza, Beatriz Bermudez-Pulgarin & Victoria Garcia-Morales. (2023) Amyotrophic Lateral Sclerosis and Serum Lipid Level Association: A Systematic Review and Meta-Analytic Study. International Journal of Molecular Sciences 24:10, pages 8675.
Crossref
Crossref
Mark R. Janse van Mantgem, Wouter van Rheenen, Anemone V. HackengMichael A. van EsJan H. Veldink, Leonard H. van den BergRuben P.A. van Eijk. (2023) Association Between Serum Lipids and Survival in Patients With Amyotrophic Lateral Sclerosis. Neurology 100:10.
Crossref
Crossref
Alisa V. Alessenko, Uliana A. Gutner & Maria A. Shupik. (2023) Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis. Life 13:2, pages 510.
Crossref
Crossref
Katherine Phan, Ying He, Surabhi Bhatia, Russell Pickford, Gordon McDonald, Srestha Mazumder, Hannah C Timmins, John R Hodges, Olivier Piguet, Nicolas Dzamko, Glenda M Halliday, Matthew C Kiernan & Woojin Scott Kim. (2023) Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis. Brain Communications 5:1.
Crossref
Crossref
Hugo Alarcan, Mélanie Berthet, Laura Suire, Corentin Colas, Loïc Gonzalez, Christophe Paget, Isabelle Benz-de Bretagne, Eric Piver, Patrick Vourc'h, Christian Andres, Philippe Corcia & Hélène Blasco. (2022) Inflammatory mediators, lipoproteins and apolipoproteins in early diagnosis of amyotrophic lateral sclerosis. SLAS Technology 27:5, pages 327-334.
Crossref
Crossref
Débora Lanznaster, Giulia Dingeo, Rayhanatou Altine Samey, Patrick Emond & Hélène Blasco. (2022) Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases. Metabolites 12:9, pages 864.
Crossref
Crossref
Nan Hu & Hongyan Ji. (2022) Medications on hypertension, hyperlipidemia, diabetes, and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. Neurological Sciences 43:9, pages 5189-5199.
Crossref
Crossref
Nora Hertel, Magdalena Kuzma-Kozakiewicz, Marta Gromicho, Julian Grosskreutz, Mamede de Carvalho, Hilmi Uysal, Reinhard Dengler, Susanne Petri & Sonja Körner. (2022) Analysis of routine blood parameters in patients with amyotrophic lateral sclerosis and evaluation of a possible correlation with disease progression—a multicenter study. Frontiers in Neurology 13.
Crossref
Crossref
Jin‐Yue Li, Li‐Ying Cui, Xiao‐Han Sun, Dong‐chao Shen, Xun‐Zhe Yang, Qing Liu & Ming‐Sheng Liu. (2022) Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology 9:7, pages 1027-1038.
Crossref
Crossref
Marc G Weisskopf, Joseph Levy, Aisha S Dickerson, Sabrina Paganoni & Maya Leventer-Roberts. (2022) Statin Medications and Amyotrophic Lateral Sclerosis Incidence and Mortality. American Journal of Epidemiology 191:7, pages 1248-1257.
Crossref
Crossref
Juan Miguel Godoy-Corchuelo, Luis C. Fernández-Beltrán, Zeinab Ali, María J. Gil-Moreno, Juan I. López-Carbonero, Antonio Guerrero-Sola, Angélica Larrad-Sainz, Jorge Matias-Guiu, Jordi A. Matias-Guiu, Thomas J. Cunningham & Silvia Corrochano. (2022) Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders. Biomedicines 10:5, pages 1105.
Crossref
Crossref
Ryutaro Nakamura, Mika Kurihara, Nobuhiro Ogawa, Akihiro Kitamura, Isamu Yamakawa, Shigeki Bamba, Mitsuru Sanada, Masaya Sasaki & Makoto Urushitani. (2022) Investigation of the prognostic predictive value of serum lipid profiles in amyotrophic lateral sclerosis: roles of sex and hypermetabolism. Scientific Reports 12:1.
Crossref
Crossref
Rosario Vasta, Ruth Chia, Bryan J. Traynor & Adriano Chiò. (2022) Unraveling the complex interplay between genes, environment, and climate in ALS. eBioMedicine 75, pages 103795.
Crossref
Crossref
Oihane Pikatza-Menoio, Amaia Elicegui, Xabier Bengoetxea, Neia Naldaiz-Gastesi, Adolfo López de Munain, Gorka Gerenu, Francisco Javier Gil-Bea & Sonia Alonso-Martín. (2021) The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis. Journal of Personalized Medicine 11:7, pages 671.
Crossref
Crossref
Emanuele D’Amico, Giuseppe Grosso, Jeri W. Nieves, Aurora Zanghì, Pam Factor-Litvak & Hiroshi Mitsumoto. (2021) Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis. Nutrients 13:7, pages 2273.
Crossref
Crossref
Aksu Gunay, Heather H. Shin, Oge Gozutok, Mukesh Gautam & P. Hande Ozdinler. (2021) Importance of lipids for upper motor neuron health and disease. Seminars in Cell & Developmental Biology 112, pages 92-104.
Crossref
Crossref
Alexandra Bouscary, Cyril Quessada, Frédérique René, Michael Spedding, Bradley J. Turner, Alexandre Henriques, Shyuan T. Ngo & Jean-Philippe Loeffler. (2021) Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Seminars in Cell & Developmental Biology 112, pages 82-91.
Crossref
Crossref
Javier Riancho, Manuel Delgado‐Alvarado, María Dolores Andreu, Lucía Paz‐Fajardo, Sara Arozamena, Francisco Javier Gil‐Bea & Adolfo López de Munaín. (2020) Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge. British Journal of Pharmacology 178:6, pages 1269-1278.
Crossref
Crossref
Yangfan Cheng, Yongping Chen & Huifang Shang. (2021) Aberrations of biochemical indicators in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Translational Neurodegeneration 10:1.
Crossref
Crossref
Gregory T. Carter, Ryan J. McLaughlin, Carrie Cuttler, Garrett J. Sauber, Douglas L. Weeks, Cecilia J. Hillard & Michael D. Weiss. (2020) Endocannabinoids and related lipids in serum from patients with amyotrophic lateral sclerosis. Muscle & Nerve 63:1, pages 120-126.
Crossref
Crossref
Jiao Liu, Xiaoyue Luo, Xueping Chen & Huifang Shang. (2020) Lipid Profile in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Frontiers in Neurology 11.
Crossref
Crossref
Beata Chełstowska & Magdalena Kuźma-Kozakiewicz. (2020) Biochemical parameters in determination of nutritional status in amyotrophic lateral sclerosis. Neurological Sciences 41:5, pages 1115-1124.
Crossref
Crossref
Caroline IngreLin ChenYiqiang ZhanJet TermorshuizenLi YinFang Fang. (2020) Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis. Neurology 94:17.
Crossref
Crossref
A.V. Alessenko, U.A. Gutner, V.O. Nebogatikov, M.A. Shupik & A.A. Ustyugov. (2020) The role of lipids in the pathogenesis of lateral amyotrophic sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 120:10, pages 108.
Crossref
Crossref
Coco Newton. 2020. Integrative and Functional Medical Nutrition Therapy. Integrative and Functional Medical Nutrition Therapy
863
912
.
Mariana Dutra Brito, Gustavo Ferro Gomes da Silva, Erick Mutti Tilieri, Beatriz Grisolia Araujo, Michele Longoni Calió & Tatiana Rosado Rosenstock. (2019) Metabolic Alteration and Amyotrophic Lateral Sclerosis Outcome: A Systematic Review. Frontiers in Neurology 10.
Crossref
Crossref
Olli Jääskeläinen, Eino Solje, Anette Hall, Kasper Katisko, Ville Korhonen, Mika Tiainen, Antti J. Kangas, Seppo Helisalmi, Maria Pikkarainen, Anne Koivisto, Päivi Hartikainen, Mikko Hiltunen, Mika Ala-Korpela, Hilkka Soininen, Pasi Soininen, Annakaisa Haapasalo, Anne M. Remes & Sanna-Kaisa Herukka. (2019) Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients. Journal of Alzheimer's Disease 72:1, pages 127-137.
Crossref
Crossref
Zihao Wang, Zhile Bai, Xiaoyan Qin & Yong Cheng. (2019) Aberrations in Oxidative Stress Markers in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Oxidative Medicine and Cellular Longevity 2019, pages 1-9.
Crossref
Crossref
Jose-Luis González De Aguilar. (2019) Lipid Biomarkers for Amyotrophic Lateral Sclerosis. Frontiers in Neurology 10.
Crossref
Crossref
Georgios Pampalakis, Konstantinos Mitropoulos, Georgia Xiromerisiou, Efthymios Dardiotis, Georgia Deretzi, Maria Anagnostouli, Theodora Katsila, Michail Rentzos & George P. Patrinos. (2019) New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis. Human Mutation 40:4, pages 361-373.
Crossref
Crossref
Carmel Armon. (2019) Smoking is a cause of amyotrophic lateral sclerosis. High low‐density lipoprotein cholesterol levels? Unsure. Annals of Neurology 85:4, pages 465-469.
Crossref
Crossref
Siobhan E. Kirk, Timothy J. Tracey, Frederik J. Steyn & Shyuan T. Ngo. (2019) Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 10.
Crossref
Crossref
Ping Zeng & Xiang Zhou. (2019) Causal effects of blood lipids on amyotrophic lateral sclerosis: a Mendelian randomization study. Human Molecular Genetics 28:4, pages 688-697.
Crossref
Crossref
Ali Jawaid, Romesa Khan, Magdalini Polymenidou & Paul E. Schulz. (2018) Disease-modifying effects of metabolic perturbations in ALS/FTLD. Molecular Neurodegeneration 13:1.
Crossref
Crossref
Acsa Nara A. B. Barros, Mário Emílio T. Dourado, Lucia de Fatima C. Pedrosa & Lucia Leite-Lais. (2018) Association of Copper Status with Lipid Profile and Functional Status in Patients with Amyotrophic Lateral Sclerosis. Journal of Nutrition and Metabolism 2018, pages 1-7.
Crossref
Crossref
Giovanna Morello, Maria Guarnaccia, Antonio Gianmaria Spampinato, Valentina La Cognata, Velia D’Agata & Sebastiano Cavallaro. (2017) Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach. Molecular Neurobiology 55:2, pages 1299-1322.
Crossref
Crossref
Anne Vejux, Amira Namsi, Thomas Nury, Thibault Moreau & Gérard Lizard. (2018) Biomarkers of Amyotrophic Lateral Sclerosis: Current Status and Interest of Oxysterols and Phytosterols. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
H Blasco, F Patin, S Molinier, P Vourc'h, O Le Tilly, S Bakkouche, C R Andres, V Meininger, P Couratier & P Corcia. (2017) A decrease in blood cholesterol after gastrostomy could impact survival in ALS. European Journal of Clinical Nutrition 71:9, pages 1133-1135.
Crossref
Crossref
J.B. Delaye, F. Patin, E. Piver, C. Bruno, M. Vasse, P. Vourc'h, C.R. Andres, P. Corcia & H. Blasco. (2017) Low IDL-B and high LDL-1 subfraction levels in serum of ALS patients. Journal of the Neurological Sciences 380, pages 124-127.
Crossref
Crossref
Ming-Dong Wang, Julian Little, James Gomes, Neil R. Cashman & Daniel Krewski. (2017) Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. NeuroToxicology 61, pages 101-130.
Crossref
Crossref